Tue, January 14, 2020
Mon, January 13, 2020
Fri, January 10, 2020
Thu, January 9, 2020
Wed, January 8, 2020
Tue, January 7, 2020
Mon, January 6, 2020
Fri, January 3, 2020
Thu, January 2, 2020
Tue, December 31, 2019

Hartaj Singh Maintained (VRTX) at Buy with Increased Target to $265 on, Jan 8th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-265-on-jan-8th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Hartaj Singh of Oppenheimer, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $230 to $265 on, Jan 8th, 2020.

Hartaj has made no other calls on VRTX in the last 4 months.



There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 0 agree with Hartaj's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Hartaj


  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $284 on, Monday, January 6th, 2020
  • Ying Huang of "B of A Securities" Reiterated at Strong Buy with Increased Target to $245 on, Wednesday, November 20th, 2019
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $229 on, Tuesday, November 19th, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $250 on, Thursday, October 31st, 2019
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $229 on, Thursday, October 31st, 2019
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019